{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "Pathogenic mutations in LRRK2 (e.g., kinase-dead version) were studied for their effects on inclusion body formation and cell death."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinsonâ€™s disease",
    "MONDO": "MONDO:0005303"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell culture and kinase activity manipulation",
      "Material used": {
        "Material Source": "Neuronal cell lines",
        "Material Name": "N.D.",
        "Description": "Experiments involved neurons and neuronal cell lines to study the effects of LRRK2 kinase activity on inclusion body formation and cell death."
      },
      "Readout type": "Qualitative and Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Inhibition of LRRK2 kinase activity reduced inclusion body formation and delayed cell death.",
          "Molecular Effect": "Reduction in toxic protein aggregation and neurodegeneration.",
          "Result Description": "Replacing the kinase domain with a kinase-dead version blocked inclusion body formation and reduced cell death in neuronal models."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}